Dexcom (DXCM) Cash from Investing Activities Growth (1y) (2011 - 2026)
Powered by 
Analysis
Dexcom (DXCM) Cash from Investing Activities Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.67 Bn | 178.06 Bn | 7.27 Bn | -15.64% |
| 2 | Intuitive Surgical | 124.18 Bn | 118.97 Bn | 1.96 Bn | -110.20% |
| 3 | Medtronic | 118.33 Bn | 109.51 Bn | 6.34 Bn | -125.17% |
| 4 | Stryker | 105.21 Bn | 101.73 Bn | 4.50 Bn | -514.42% |
| 5 | Boston Scientific | 66.61 Bn | 66.07 Bn | 3.85 Bn | -73.71% |
| 6 | Edwards Lifesciences | 49.73 Bn | 45.47 Bn | 1.35 Bn | -12.26% |
| 7 | Alcon | 33.91 Bn | 32.46 Bn | 1.68 Bn | -44.16% |
| 8 | Dexcom | 32.28 Bn | 30.34 Bn | 830.00 Mn | 618.55% |
| 9 | Steris | 21.09 Bn | 20.61 Bn | 684.20 Mn | 0.00% |
| 10 | Zimmer Biomet Holdings | 18.18 Bn | 17.77 Bn | 1.54 Bn | 86.22% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 618.55% |
| Mar 31, 2026 | -397.90% |
| Dec 31, 2025 | 200.95% |
| Sep 30, 2025 | -8.32% |
| Jun 30, 2025 | 66.33% |
| Mar 31, 2025 | 33.96% |
| Dec 31, 2024 | -173.20% |
| Sep 30, 2024 | 217.16% |
| Jun 30, 2024 | 66.02% |
| Mar 31, 2024 | 140.06% |
| Dec 31, 2023 | 313.76% |
| Sep 30, 2023 | -178.28% |
| Jun 30, 2023 | -283.64% |
| Mar 31, 2023 | 54.66% |
| Dec 31, 2022 | 60.87% |
| Sep 30, 2022 | 690.69% |
| Jun 30, 2022 | -139.90% |
| Mar 31, 2022 | -267.02% |
| Dec 31, 2021 | -1,967.08% |
| Sep 30, 2021 | 411.83% |